维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

15篇 您的检索式：作者名="Angelo SP"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Cytotoxicity of Captafol in Mammalian Cells显示文摘The cytotoxicity of captafol, a phthalimide-derived fungicide, was evaluated in IB-RS-2 cells. Captafol at 0. 12-1 .0μg/ml blocks the cell multiplication. This effect is concentrationdependent, only partially rcversible and the degree of inhibition increases with time. The synthesis of DNA and RNA is inhibited in parallel by increasing concentrations of the	M. A. LA R. RODRIGUES AND M. D’ANGELO (Instituto Biologico, Caixa Postal 7119, 01064-970, Sao Paulo, SP Brazil)	1994	Biomedical and Environmental Sciences1994，7，3：	2
	2	-Nivolumab versus chemotherapy in patients with advanced melano- ma who progressed after anti-CTLA-4 treatment (CheckMate 037 ) : a randomised, controlled, open- label, phase 3 trial 显示文摘	Weber JS D'Angelo SP Minor D	2015	Lancet Oncol2015，16，4：	1
	3	The molecular pathogenesis of small cell lung cancer显示文摘	D'Angelo SP Pietanza MC	2010	Cancer Biol Ther2010，10，1：	1
	4	Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib显示文摘	D'Angelo SP Janjigian YY Ahye N	2012	J Thorac Oncol2012，7，12：	1
	5	Rapid eradication of a bulky melanoma mass with one dose of immunotherapy 显示文摘	Chapman PB D'Angelo SP Wolchok JD	2015	N Engl J Med2015，372，21：	1
	6	Distinct clinical course of EGFR-mutant resected lung cancers:results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib显示文摘	D'Angelo SP Janjigian YY Ahye N	2012	J Thorac Oncol2012，7，12：	1
	7	Distinct clinical course of EGFR-mutant resected lung cancers:results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib显示文摘	D'Angelo SP Janjigian YY Ahye N		0，，12：	1
	8	Incidence of EGFR exon 19 deletion and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas 显示文摘	D~Angelo SP Pietanza MC Johnson ML	2011	J ClinOncol2011，29，15：	1
	9	Re ex testing of resected stage I through III lung adenocarcinomas for EGFR and KRAS mutation:report on initial experience and clinical utility at a single center显示文摘	D'Angelo SP Park B Azzoli CG	2011	J Thorac Cardiovasc Surg2011，141，：	1
	10	Prevalence of tumor-infiltrating lymphoeytes and PD-L1 expression in the soft tissue sarcoma mieroenvironment 显示文摘	D'Angelo SP Shoushtari AN Agaram NP	2015	Hum Pathol2015，46，3：	1
	11	Preva-lence of tumor-infiltrating lymphocytes and PD-L1 ex-pression in the soft tis- sue sarcoma microenvimnment显示文摘	D' Angelo SP Shoushtari AN Agaram NP	2014	Hum Patho12014，46，3：	1
	12	Incidence of EG-FR exon 19 deletions and L858R in tumor specimens from menand cigarette smokers with lung adenocarcinomas 显示文摘	D Angelo SP Pietanza MC Johnson ML	2011	J Clin On-col2011，29，15：	1
	13	Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cig- arette smokers with lung adenocarcinomas显示文摘	D' Angelo SP Pietanza MC Johnson ML	2011	J Clin Oncol2011，29，15：	1
	14	Incidence of EGFR ex-on 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas显示文摘	D′Angelo SP Pietanza MC Johnson ML		0，，：	1
	15	Associations between mutations and histologic patterns of mucin in lung adenocarcinoma:Invasive mucinous pattern and extracellular mucin are associated with KRAS mutation显示文摘	Kadota K Yeh YC D'Angelo SP	2014	Am J Surg Pathol2014，38，8：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费